Heath, E. I., George, D. J., Sartor, A. O., Shore, N. D., Nguyen, J., Patel, J., Sawhney, A., Kang, B., Byrne, C., LaVallee, C., Wei, X. X. (2026). [
                    <sup>177</sup>
                    Lu]Lu-PSMA-617 (
                    <sup>177</sup>
                    Lu-PSMA-617) in combination with an androgen receptor pathway inhibitor (ARPI) versus
                    <sup>177</sup>
                    Lu-PSMA-617 alone for the treatment of metastatic castration-resistant prostate cancer (mCRPC): A real-world prostate cancer disease observation (PRECISION) data platform analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.78